- Ownership hops held
- 17
An absent edge means not yet observed — never does not exist.
TRILLIUM THERAPEUTICS INC.
TRILLIUM THERAPEUTICS INC. — US company (sec:0001616212). UBO chain traced 17 hops. Every claim linked to its source.
Ownership resolves 17 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
No ownership or control links resolved yet
An absent link means “not yet observed in our current sources”, not that none exists — cross-source resolution is still growing.
We flag the moment ownership, a filing or a sanctions signal lands on it — the fastest way to catch a change on a subject we hold little on today.
17-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on TRILLIUM THERAPEUTICS INC., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
People & control
14 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- BESHAR LUKE MAlso holds roles at 5 other companies
- CAMBREX CORPofficer
- Protara Therapeutics, Inc.director
- Omega Therapeutics, Inc.director
- KAMARCK MICHAEL E.Also holds roles at 6 other companies
- Passage BIO, Inc.director
- Vaxcyte, Inc.director
- Vir Biotechnology, Inc.officer
- KIRKMAN ROBERT LAlso holds roles at 3 other companies
- ONCORUS, INC.director
- BIOMIRA CORPdirector
- BIOMIRA CORPofficer
- MACKEY CATHERINE JAlso holds roles at 6 other companies
- Avid Bioservices, Inc.director
- IDEAYA Biosciences, Inc.director
- Voyager Therapeutics, Inc.director
- MYERS SCOTT DUNSETHAlso holds roles at 11 other companies
- Zentalis Pharmaceuticals, Inc.director
- DYNAVAX TECHNOLOGIES CORPdirector
- HARPOON THERAPEUTICS, INC.director
- Parsons James T.Also holds roles at 2 other companies
- DiaMedica Therapeutics Inc.director
- ONCOLYTICS BIOTECH INCdirector
- PUCCI PAOLOAlso holds roles at 9 other companies
- WEST PHARMACEUTICAL SERVICES INCdirector
- Replimune Group, Inc.director
- Merus N.V.director
- Skvarka JanAlso holds roles at 2 other companies
- Zentalis Pharmaceuticals, Inc.director
- Monte Rosa Therapeutics, Inc.director
- TAYTON-MARTIN HELEN KATRINAAlso holds roles at 2 other companies
- EVAXION A/Sofficer
- Adaptimmune Therapeutics PLCofficer
- WALKER PAUL EDWARDAlso holds roles at 22 other companies
- Korro Bio, Inc.tenpercentowner
- Trevi Therapeutics, Inc.tenpercentowner
- SPYGLASS OPHTHALMICS, INC.tenpercentowner
14 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns TRILLIUM THERAPEUTICS INC.?
- What is TRILLIUM THERAPEUTICS INC.'s risk level?
- Where does TRILLIUM THERAPEUTICS INC. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for TRILLIUM THERAPEUTICS INC. — nothing is disclosed before that.